Amway India’s losses in the financial year ending March 31, 2025, expanded to Rs 74.25 crore from Rs 53.38 crore in the previous year. Revenue dropped by 10.56% to Rs 1,148.16 crore in FY25 from Rs 1,283.75 crore in FY24. The company’s total income, including other income, decreased by 9.2% to Rs 1,174.85 crore during the year.
Despite the revenue decline, Amway India managed to reduce various costs in FY25. Spending on advertising and sales promotion notably decreased by 40.6% to Rs 36.20 crore. The royalty paid to its US-based parent company also saw a 15.7% reduction to Rs 55.43 crore from Rs 65.74 crore in the previous financial year. Payments to Amway India’s sole selling agents slightly dropped by 2.73% to Rs 366.91 crore in FY25.
Overall, the company’s total expenses decreased by 7.3% to Rs 1,249.10 crore during the year. Amway India, a subsidiary of Alticor Global Holdings Inc, headquartered in Ada, Michigan, is among the world’s largest direct selling companies, remaining unlisted in India.
Segment-wise, Amway India witnessed declines across major categories. Revenue from its largest segment, nutrition and wellness, fell by 10% to Rs 703.58 crore in FY25. The personal care segment, the second largest, experienced a sharper decline of 13.6%, with revenue at Rs 189.22 crore. Revenue from home care products slipped by 2.65% to Rs 120.29 crore, while the beauty segment reported a 12% fall to Rs 96.59 crore during the financial year.
